Fora Capital, LLC Gossamer Bio, Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$8.3 - $13.59 $27,066 - $44,316	-3,261 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $31,044 - $52,110	3,261 New	3,261 $42 Million
Q1 2020 May 15, 2020	SELL	$8.0 - $15.48 $182,664 - $353,454	-22,833 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$14.82 - $26.79 $338,385 - $611,696	22,833 New	22,833 $356,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.